Synthesis, Molecular Docking, and Preclinical Evaluation of a New Succinimide Derivative for Cardioprotective, Hepatoprotective and Lipid-Lowering Effects.

Molecules · 2022 · PMC9573045 · PMID 36234730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The results obtained for the groups treated with the test Comp-1 showed a highly significant reduction in the levels of TC, TG, LDL-c, and VLDL-c and an increased the level of HDL-c at the dose of 10 mg/kg.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.